Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk

被引:26
作者
Bozzetto, L. [1 ]
Annuzzi, G. [1 ]
Ragucci, M. [2 ]
Di Donato, O. [2 ]
Della Pepa, G. [1 ]
Della Corte, G. [1 ]
Griffo, E. [1 ]
Anniballi, G. [1 ]
Giacco, A. [1 ]
Mancini, M. [3 ]
Rivellese, A. A. [1 ]
机构
[1] Univ Naples Federico II, Dept Clin Med & Surg, Via Pansini 5, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Adv Biomed Sci, I-80131 Naples, Italy
[3] CNR, Inst Biostruct & Bioimaging, Naples, Italy
关键词
NAFLD; GLP-1; Inflammation; HDL; Insulin resistance; IFN-g; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; DIABETES-MELLITUS; DYSLIPIDEMIA; INFLAMMATION; OBESITY; HITS;
D O I
10.1016/j.numecd.2016.01.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: The role of the different factors associated with fatty liver is still poorly defined. We evaluated the relationships between liver fat content (LF) and metabolic, inflammatory and nutritional factors in a homogeneous cohort of individuals at high cardio-metabolic risk. Methods and results: In 70 individuals with high waist circumference and at least one more criterion for metabolic syndrome enrolled in a nutritional intervention study, LF was evaluated at baseline by hepatic/renal echo intensity ratio (H/R), together with dietary habits (7-day dietary record), insulin sensitivity and beta-cell function (fasting and OGTT-derived indices), fasting and postprandial plasma GLP-1 and lipoproteins, and plasma inflammatory markers. H/R correlated positively with fasting and OGTT plasma glucose and insulin concentrations, HOMA-IR and beta-cell function, and IL-4, IL-17, IFN-gamma, TNF-alpha, FGF and GCSF plasma concentrations (p < 0.05 for all), and negatively with insulin sensitivity (OGIS), dietary, polyphenols and fiber (p < 0.05 for all). By multiple stepwise regression analysis, the best predictors of H/R were OGIS (beta = -0.352 p = 0.001), postprandial GLP-1 (beta = -0.344; p = 0.001), HDL-cholesterol (beta = -0.323; p = 0.002) and IFN-gamma (beta = 0.205; p = 0.036). Conclusion: A comprehensive evaluation of factors associated with liver fat, in a homogeneous population at high cardio-metabolic risk, indicated a pathogenic combination of the same pathways underlying the atherosclerotic process, namely whole body insulin sensitivity and inflammation. The higher predictive value of postprandial variables suggests that liver fat is essentially a postprandial phenomenon, with a relevant role possibly played by GLP-1. (C) 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:623 / 629
页数:7
相关论文
共 30 条
[11]   Active glucagon-like peptide-1 (GLP-1): Storage of human plasma and stability over time [J].
Di Marino, Lucrezia ;
Griffo, Ettore ;
Maione, Simona ;
Mirabella, Martina .
CLINICA CHIMICA ACTA, 2011, 412 (17-18) :1693-1694
[12]   Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals [J].
Finucane, Francis M. ;
Sharp, Stephen J. ;
Hatunic, Mensud ;
Sleigh, Alison ;
Rolfe, Ema De Lucia ;
Sayer, Avan Aihie ;
Cooper, Cyrus ;
Griffin, Simon J. ;
Wareham, Nicholas J. .
DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
[13]   Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease [J].
Gaggini, Melania ;
Morelli, Mariangela ;
Buzzigoli, Emma ;
DeFronzo, Ralph A. ;
Bugianesi, Elisabetta ;
Gastaldelli, Amalia .
NUTRIENTS, 2013, 5 (05) :1544-1560
[14]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[15]   Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance [J].
Kahl, Sabine ;
Strassburger, Klaus ;
Nowotny, Bettina ;
Livingstone, Roshan ;
Klueppelholz, Birgit ;
Kessel, Kathrin ;
Hwang, Jong-Hee ;
Giani, Guido ;
Hoffmann, Barbara ;
Pacini, Giovanni ;
Gastaldelli, Amalia ;
Roden, Michael .
PLOS ONE, 2014, 9 (04)
[16]   Does Interleukin-17 Play the Villain in Nonalcoholic Steatohepatitis? [J].
Kisseleva, Tatiana .
HEPATOLOGY, 2014, 59 (05) :1671-1672
[17]   Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes [J].
Kotronen, Anna ;
Juurinen, Leena ;
Tiikkainen, Mirja ;
Vehkavaara, Satu ;
Yki-Jarvinen, Hannele .
GASTROENTEROLOGY, 2008, 135 (01) :122-130
[18]   Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question [J].
Loria, P. ;
Lonardo, A. ;
Bellentani, S. ;
Day, C. P. ;
Marchesini, G. ;
Carulli, N. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2007, 17 (09) :684-698
[19]   Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with 1H magnetic resonance spectroscopy [J].
Mancini, Marcello ;
Prinster, Anna ;
Annuzzi, Giovanni ;
Liuzzi, Raffaele ;
Giacco, Rosalba ;
Medagli, Carmela ;
Cremone, Matteo ;
Clemente, Gennaro ;
Maurea, Simone ;
Riccardi, Gabriele ;
Rivellese, Angela Albarosa ;
Salvatore, Marco .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (12) :1724-1730
[20]   Nonalcoholic fatty liver disease - A feature of the metabolic syndrome [J].
Marchesini, G ;
Brizi, M ;
Bianchi, G ;
Tomassetti, S ;
Bugianesi, E ;
Lenzi, M ;
McCullough, AJ ;
Natale, S ;
Forlani, G ;
Melchionda, N .
DIABETES, 2001, 50 (08) :1844-1850